What is the recommended outpatient management for ascites, including low‑sodium diet, diuretic regimen, and criteria for therapeutic paracentesis or TIPS?

Outpatient Ascites Treatment

For outpatient management of cirrhotic ascites, initiate sodium restriction to ≤2000 mg/day (87-90 mmol/day) combined with spironolactone 100 mg daily, adding furosemide 40 mg daily for moderate-to-severe ascites or when faster diuresis is needed, with therapeutic paracentesis reserved for tense ascites or refractory cases. 1, 2, 3

Dietary Management

Sodium restriction is the cornerstone of outpatient ascites management. Limit dietary sodium to 2000 mg/day (87-90 mmol sodium), which translates to a "no added salt" diet with avoidance of precooked/preprepared meals 1, 2, 3. The 2021 Gut guidelines and 2025 AGA update both emphasize this threshold as optimal—strict enough to achieve negative sodium balance without risking malnutrition 1, 2.

• Refer all patients to a dietitian for education on label reading, cooking techniques, and sodium content of common foods 2, 3
• Target adequate protein intake (1.2-1.5 g/kg/day) and calories (≥35 kcal/kg/day in non-obese patients) to prevent sarcopenia 2, 3
• Fluid restriction is NOT necessary unless serum sodium drops below 120-125 mmol/L 1, 3

Diuretic Regimen

First-Line Therapy

The approach differs based on ascites severity:

For first presentation of moderate ascites: Start with spironolactone monotherapy at 100 mg daily, titrating up to 400 mg as needed 1, 2. This approach minimizes side effects while achieving adequate response in most patients with new-onset ascites 3.

For recurrent or severe ascites, or when hospitalized: Use combination therapy from the start—spironolactone 100 mg plus furosemide 40 mg daily in a 100:40 ratio 1, 2, 3. This combination enhances natriuresis while maintaining normokalemia and outperforms monotherapy or sequential addition 2.

Dose Titration

• Increase doses every 3-5 days based on response, maintaining the 100:40 ratio 4, 3
• Maximum doses: spironolactone 400 mg/day, furosemide 160 mg/day 4, 1, 3
• Target weight loss: 0.5 kg/day without peripheral edema; up to 1 kg/day with edema 2, 3
• Patients should weigh themselves daily at the same time 3

Monitoring for Adverse Effects

Close monitoring is essential—nearly half of patients experience adverse events requiring dose adjustment 1:

• Check electrolytes and renal function within the first weeks of treatment 3
• Reduce or stop diuretics if:
  • Serum creatinine ≥2.0 mg/dL
  • Serum sodium <120 mmol/L
  • Serum potassium >6.0 mmol/L
  • Development of hepatic encephalopathy
  • Severe muscle cramps 4, 5, 3

For hyperkalemia: Reduce or stop spironolactone 5
For hypokalemia: Reduce or stop furosemide 5

Assessing Response

Use spot urine sodium-to-potassium ratio to guide therapy 3:

• If spot urine Na/K ratio >1: Patient should be losing weight; if not, suspect dietary non-compliance
• If spot urine Na/K ratio ≤1: Insufficient natriuresis; increase diuretic doses

Therapeutic Paracentesis

Indications for Large-Volume Paracentesis (LVP)

Perform initial therapeutic paracentesis for tense ascites to provide rapid symptom relief, then initiate sodium restriction and diuretics 4, 6. This approach removes fluid in minutes versus days-to-weeks with diuretics alone.

For diuretic-sensitive patients, serial paracentesis is inappropriate—these patients should be managed with sodium restriction and oral diuretics rather than repeated procedures 6.

Albumin Replacement

• Infuse 8 g albumin per liter of ascites removed when >5 L is drained 1, 5, 1
• For paracentesis <5 L, albumin can be considered in high-risk patients (those with acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury) 1
• Use 20% or 25% albumin solution 1

Ultrasound Guidance

Consider ultrasound guidance when available to reduce risk of adverse events 1. Routine measurement of PT/INR and platelet count before paracentesis is NOT recommended, and blood product infusion is not needed 1.

Refractory Ascites

Refractory ascites is defined as:

1. Unresponsive to sodium restriction and maximum-dose diuretics (spironolactone 400 mg/day + furosemide 160 mg/day), OR
2. Rapid recurrence after therapeutic paracentesis 4, 6

Management Options

For refractory ascites, the hierarchy is:

1. Serial large-volume paracentesis with albumin replacement (8 g/L removed) every 2-4 weeks as needed 4, 5
2. TIPS placement in carefully selected patients 1:
   • Consider in younger patients with reasonable liver reserve
   • Exercise caution if: age >70 years, bilirubin >50 μmol/L (>3 mg/dL), platelets <75×10⁹/L, MELD ≥18, current hepatic encephalopathy, active infection, or hepatorenal syndrome 1
3. Liver transplantation evaluation—all patients with ascites should be assessed for transplant candidacy 4, 6

Emerging Therapies

Midodrine may be considered on a case-by-case basis for refractory ascites, though evidence is limited 1. Long-term albumin infusions (weekly to biweekly) may delay progression to refractoriness, but this remains investigational 7, 8.

Critical Pitfalls to Avoid

• Never use NSAIDs—they reduce urinary sodium excretion and can convert diuretic-sensitive patients to refractory 4, 6
• Avoid ACE inhibitors and angiotensin receptor blockers in patients with ascites 5
• Do not use loop diuretics as monotherapy—aldosterone antagonists must be the foundation 5
• Do not restrict fluids unless severe hyponatremia (<120-125 mmol/L) is present 4, 1, 3
• Avoid excessive diuresis (>0.5 kg/day without edema) to prevent plasma volume contraction and renal failure 3

Follow-Up Schedule

• Evaluate every 2-4 weeks initially until response is established and complications are ruled out 6
• Once stable, follow-up every few months may be appropriate 6
• All hospitalized patients with ascites require diagnostic paracentesis within 12-24 hours of admission to rule out spontaneous bacterial peritonitis 2